Corsantrum Technology

Product Introduction 

Hervycta 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Hervycta 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

Uses of Hervycta 440mg Injection

Hervycta 440mg Injection is indicated for its use in the following conditions:

• Advanced and metastatic breast cancer

• Metastatic gastric cancer

Therapeutic Effects of Hervycta 440mg Injection

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hervycta 440mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Interaction of Hervycta 440mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hervycta 440mg Injection and cause undesirable side effects.

More Information about Hervycta 440mg Injection

• Keep Hervycta 440mg Injection out of sight and reach of children.

• Store between 2˚C and 8˚C.

How to consume Hervycta 440mg Injection

• Hervycta 440mg Injection shall either be administered before or after surgery.

• It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side Effects of Hervycta 440mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious :

• Heart Problems

• Allergic reactions

• Kidney problems

• Breathing difficulties

Common :

• Fever

• Visual disturbances

• Nose bleeds or runny nose

• Hair loss

• Dizziness

• Nail disorders

• Weight loss

• Loss of appetite

• Bruising

• Dry mouth

• Liver  inflammation

• Muscle pain

• Asthma/ lung disorders

Word of Advice

It is suggested to inform your doctor if you have a history of allergic reactions to Hervycta 440mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with BiceHervycta ltis 440mg Injection as it may impact the functioning of heart.

PRODUCT INTRODUCTION

Hermab 440mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Hermab 440mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF HERMAB INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF HERMAB INJECTION

In Breast cancer

Hermab 440mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Hermab 440mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF HERMAB INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Hermab

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE HERMAB INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE HERMAB INJECTION?

If you miss a dose of Hermab 440mg Injection, please consult your doctor.

PRODUCT INTRODUCTION

Herticad 440mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Herticad 440mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF HERTICAD INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF HERTICAD INJECTION

In Breast cancer

Herticad 440mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Herticad 440mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF HERTICAD INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Herticad

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE HERTICAD INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE HERTICAD INJECTION?

If you miss a dose of Herticad 440mg Injection, please consult your doctor.

The prescription oncology medication LuciNera 40mg contains neratinib, a tyrosine kinase inhibitor (TKI) that is primarily used as an extended adjuvant treatment for early-stage HER2-positive breast cancer. Manufactured as oral tablets, LuciNera is targeted therapy designed to help prevent the recurrence of breast cancer after the completion of initial treatments such as surgery, chemotherapy, and trastuzumab-based therapy. The advanced action of Neratinib makes it a valuable addition to the long-term management of HER2-positive breast cancer, reducing the likelihood of disease relapse.

Neratinib is a strong, irreversible pan-HER tyrosine kinase inhibitor that is found in LuciNera. It selectively targets HER1 (EGFR), HER2, and HER4 receptors that are overexpressed in certain types of cancer, particularly HER2-positive breast cancer. By blocking these receptors, Neratinib inhibits cancer cell growth and proliferation.

LuciNera is typically prescribed following the completion of a trastuzumab-based therapy regimen and is considered a preventive measure to reduce the risk of breast cancer recurrence.

In order to permanently block the intracellular kinase domain of the HER receptors (HER1, HER2, and HER4), neratinib binds to it. These receptors are essential for signaling pathways that promote cell growth and survival. In HER2-positive malignancies, overexpression of HER2 results in uncontrolled cell proliferation.

By inhibiting these kinases, LuciNera effectively blocks downstream signaling cascades, including the PI3K/AKT and MAPK pathways, thereby stopping the growth and division of cancer cells. Its irreversible action provides prolonged inhibition, which is particularly useful in cancer cells with high HER receptor activity.

LuciNera 40mg is primarily indicated for:

• Adult patients with early-stage HER2-positive breast cancer may benefit from prolonged adjuvant treatment to lower their chance of recurrence.

• It is especially used in patients who have completed a trastuzumab-based therapy regimen within the previous 1 year.

• Ongoing research is exploring its use in metastatic settings and other HER2-driven cancers, but its current FDA-approved and widely accepted use is in the extended adjuvant setting for breast cancer.

Like all cancer therapies, LuciNera may cause side effects. The most commonly reported include:

• Diarrhea (often severe; prophylactic loperamide is recommended)

• Nausea, vomiting

• Fatigue

• Abdominal pain

• Decreased appetite

• Rash or skin reactions

• Liver enzyme elevation

• The use of LuciNera 40mg provides several clinical benefits:

• lowers the chance of recurrence in people with HER2-positive breast cancer.

• is a proven effective oral at-home treatment alternative.

• Extends disease-free survival (DFS), especially in hormone receptor-positive patients.

• Irreversible inhibition provides sustained suppression of cancer-driving pathways.

• Its use has become a significant part of personalized oncology, offering post-trastuzumab patients an additional layer of protection against relapse.

LuciTuca 150mg contains Tucatinib, a targeted therapy used primarily in the treatment of certain types of HER2-positive breast cancer. It represents a significant advancement in oncology, particularly in managing advanced or metastatic breast cancer that has spread beyond the breast, including to the brain. Tucatinib, developed as a selective HER2 tyrosine kinase inhibitor, is a valuable tool in the evolving landscape of personalized cancer therapy.

LuciTuca 150mg is an oral medication used in combination with other drugs to treat HER2-positive metastatic breast cancer. It is typically prescribed when the disease has progressed following treatment with other HER2-targeted therapies. Tucatinib is approved for use alongside trastuzumab and capecitabine, providing a multi-targeted approach to cancer management.

Tucatinib works by selectively inhibiting HER2 (human epidermal growth factor receptor 2), a protein that promotes the growth of cancer cells. Overexpression of HER2 occurs in about 20% of breast cancers and is associated with aggressive tumor behavior.

• Selective Inhibition: Tucatinib binds specifically to the HER2 receptor's tyrosine kinase domain, blocking its phosphorylation and activation.

• Reduced Signaling: This action prevents downstream signaling through pathways like PI3K/AKT and MAPK, which are crucial for cancer cell survival and proliferation.

• Blood-Brain Barrier Penetration: Tucatinib has the ability to cross the blood-brain barrier, making it effective against brain metastases, a common and difficult-to-treat complication in HER2-positive cancers.

Indications:

Adult patients who take 150 mg of LuciTuca have:

• Advanced or metastatic HER2-positive breast cancer

• Individuals who have already had anti-HER2-based treatment

• Those with or without brain metastases

• It is prescribed in combination with trastuzumab and capecitabine to increase effectiveness.

Standard Dosage:

• Tucatinib (LuciTuca): 300 mg per day, taken as 150 mg twice daily

• To be taken with trastuzumab and capecitabine, as per individual dosing schedules

Administration:

• Oral route with or without food

• Swallow tablets whole with water

• Maintain a consistent time schedule to ensure steady drug levels

Changes in dosage may be required in the following situations:

• Hepatic impairment: Patients who have liver dysfunction may need to take a lower dose.

• Renal impairment: Although mild to moderate renal issues may not require changes, severe cases should be monitored closely.

• Adverse effects: If serious side effects occur (like severe diarrhea or liver toxicity), dose interruption or reduction is considered.

Like all medications, LuciTuca 150mg has potential side effects. These vary in severity and frequency.

• Diarrhea

• Hand-foot syndrome (palmar-plantar erythrodysesthesia)

• Nausea and vomiting

• Fatigue

• Liver enzyme elevation (ALT/AST)

• Abdominal pain

• Decreased appetite

• Hepatotoxicity: Requires liver function monitoring.

• Severe diarrhea and dehydration: May require supportive care or dose interruption.

• Interstitial lung disease/pneumonitis: Though rare, it's potentially life-threatening.

• Patients should be checked routinely, especially during the first few weeks of treatment.

Product Introduction

Priunta 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Priunta 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

Uses of Priunta 440mg Injection

Priunta 440mg Injection is indicated for its use in the following conditions:

• Advanced and metastatic breast cancer

• Metastatic gastric cancer

Therapeutic Effects of Priunta 440mg Injection

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth.

Interaction of Priunta 440mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Priunta 440mg Injection and cause undesirable side effects.

More Information about Priunta 440mg Injection

• Keep Priunta 440mg Injection out of sight and reach of children.

• Store between 2˚C and 8˚C.

How to consume Priunta 440mg Injection

• Priunta 440mg Injection shall either be administered before or after surgery.

• It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side Effects of Priunta 440mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious :

• Heart Problems

• Allergic reactions

• Kidney problems

• Breathing difficulties

Common : 

• Fever

• Visual disturbances

• Nose bleeds or runny nose

• Hair loss

• Dizziness

• Nail disorders

• Weight loss

• Loss of appetite

• Bruising

• Dry mouth

• Liver  inflammation

• Muscle pain

• Asthma/ lung disorders

Word of Advice

It is suggested to inform your doctor if you have a history of allergic reactions to Priunta 440mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Priunta  440mg Injection as it may impact the functioning of heart.

Product Introduction 

Hervycta 150mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Hervycta 150mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

Uses of Hervycta 150mg Injection

Hervycta 150mg Injection is indicated for its use in the following conditions:

• Advanced and metastatic breast cancer

• Metastatic gastric cancer

Therapeutic Effects of Hervycta 150mg Injection

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hervycta 150mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Interaction of Hervycta 150mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hervycta 150mg Injection and cause undesirable side effects.

More Information about Hervycta 150mg Injection

• Keep Hervycta 150mg Injection out of sight and reach of children.

• Store between 2˚C and 8˚C.

How to consume Hervycta 150mg Injection

• Hervycta 150mg Injection shall either be administered before or after surgery.

• It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Side Effects of Hervycta 150mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious :

• Heart Problems

• Allergic reactions

• Kidney problems

• Breathing difficulties

Common :

• Fever

• Visual disturbances

• Nose bleeds or runny nose

• Hair loss

• Dizziness

• Nail disorders

• Weight loss

• Loss of appetite

• Bruising

• Dry mouth

• Liver  inflammation

• Muscle pain

• Asthma/ lung disorders

Word of Advice

It is suggested to inform your doctor if you have a history of allergic reactions to Hervycta 150mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Hervycta 150mg Injection as it may impact the functioning of heart.

PRODUCT INTRODUCTION

Trasturel 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Trasturel 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF TRASTUREL INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF TRASTUREL INJECTION

In Breast cancer

Trasturel 150mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Trasturel 150mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF TRASTUREL INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Trasturel

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE TRASTUREL INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE TRASTUREL INJECTION?

If you miss a dose of Trasturel 150mg Injection, please consult your doctor.

PRODUCT INTRODUCTION

Hertraz 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Hertraz 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF HERTRAZ INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF HERTRAZ INJECTION

In Breast cancer

Hertraz 150mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Hertraz 150mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF HERTRAZ INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Hertraz

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE HERTRAZ INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE HERTRAZ INJECTION?

If you miss a dose of Hertraz 150mg Injection, please consult your doctor.

Product Information

Hervycta Plus 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Hervycta Plus 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses Of Hervycta Plus 150mg Injection

• Breast cancer

• Stomach cancer

Benefits Of Hervycta Plus 150mg Injection

In Breast cancer

Hervycta Plus 150mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Hervycta Plus 150mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

Side Effects Of Hervycta Plus 150mg Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Hervycta Plus 150mg

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

How To Use Hervycta Plus 150mg Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

What If You Forget To Take Hervycta Plus 150mg Injection?

If you miss a dose of Hervycta Plus 150mg Injection, please consult your doctor.

PRODUCT INTRODUCTION

Hermab 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Hermab 150mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF HERMAB INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF HERMAB INJECTION

In Breast cancer

Hermab 150mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Hermab 150mg Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF HERMAB INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Hermab

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE HERMAB INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE HERMAB INJECTION?

LuciAbe 50mg contains abemaciclib, a targeted therapy utilized in treating specific breast cancer types. This document outlines detailed information regarding its application, operational mechanism, potential side effects, and other essential details.

LuciAbe (Abemaciclib) is a brand name (which may vary regionally; Verzenio is the primary brand name in many areas) for abemaciclib, a kinase inhibitor. Cyclin-dependent kinase (CDK) 4 and 6 inhibitors are a class of medications that are essential for cell division. By hindering CDK4 and CDK6 activity, abemaciclib aids in decelerating or halting the growth and dissemination of cancer cells.

Abemaciclib selectively obstructs the activity of CDK4 and CDK6 enzymes essential for cell cycle progression, particularly during the transition from the G1 to the S phase, where DNA replication occurs. In numerous cancers, these kinases are overactive, resulting in unchecked cell proliferation.

• Prevents Rb Protein Phosphorylation: When unphosphorylated, the retinoblastoma (Rb) protein functions as a tumor suppressor, hindering cells from advancing to the S phase. Rb becomes inactive due to phosphorylation by CDK4/6, which promotes cell cycle advancement. Abemaciclib maintains Rb in its functional, unphosphorylated form, thus inhibiting cell cycle advancement.

• Promotes Cell Cycle Arrest and Suppresses Cancer Cell Growth: This process aids in retarding the proliferation of hormone receptor-positive (HR+), HER2-negative breast cancer cells where the CDK4/6 pathway is frequently dysregulated.

LuciAbe 50mg tablets should be taken orally twice a day, approximately 12 hours apart, at consistent times each day. It can be taken with or without food, but maintaining consistency regarding meals is advised. Swallow the tablets whole with water—do not crush, chew, or split them. If a dose is missed, do not take an extra dose; just resume with the next scheduled dose. If vomiting happens after taking a dose, take the next planned dose instead of taking another one.

LuciAbe may induce various side effects, some of which could be severe. It’s important to recognize these potential effects and discuss any concerns with your physician promptly.

• Diarrhea: A very common side effect, potentially severe, especially in the initial month. Your doctor may suggest antidiarrheal medications and guidance on hydration.

• Fatigue: Common fatigue or weakness.

• Nausea and Vomiting: Manageable occurrences.

• Abdominal Pain: Discomfort in the region of the stomach.

• Decreased Appetite: Disinterest in eating.

• Headaches: Occasional pain in the head.

• Dizziness: Lightheadedness or unsteadiness.

• Infections: Due to reduced white blood cell counts, increasing infection risk. Report signs of infection (fever, chills) immediately.

• Breathlessness and exhaustion are symptoms of anemia.

• Thrombocytopenia: Low platelet counts causing easy bruising or bleeding.

• Leukopenia or Neutropenia: Heightened infection risk.

• Alopecia: Thinning or loss of hair, generally less severe compared to conventional chemotherapy.

• Rash and Itching: Possible skin reactions.

LuciAbe (abemaciclib) requires a prescription and can only be obtained through a valid order from a qualified healthcare provider (oncologist), specifying dosage, frequency, and treatment duration.

Capivasertib is an oral medication primarily used in oncology to treat certain types of advanced breast cancer. It functions as a potent inhibitor of the AKT signaling pathway, which is often dysregulated in various cancers.

Capivasertib is a small-molecule, oral drug that targets all three isoforms of the AKT enzyme (AKT1, AKT2, and AKT3). By inhibiting AKT, capivasertib disrupts critical downstream signaling pathways involved in cell survival, growth, and metabolism, thereby exerting antitumor effects .

LuciCapiva is primarily used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in adults, especially those who have specific genetic alterations such as mutations in the PIK3CA, AKT1, or PTEN genes.

Capivasertib works by inhibiting the AKT protein, a crucial component of the PI3K/AKT/mTOR signaling pathway, which plays a significant role in cancer cell growth, survival, and resistance to therapy. When this pathway becomes overactive—often due to mutations—it can promote cancer progression and resistance to conventional treatments like endocrine therapy.

Capivasertib is typically used in combination with fulvestrant in patients who have progressed on prior endocrine therapies .

• Hormone receptor-positive (HR+)

• Human epidermal growth factor receptor 2-negative (HER2-)

• Locally advanced or metastatic breast cancer

Who have one or more alterations in the PI3K/AKT/PTEN pathway, specifically:

• PIK3CA mutation

• AKT1 mutation

• PTEN loss or mutation

• And have progressed on at least one endocrine-based therapy (e.g., aromatase inhibitors, tamoxifen, or fulvestrant alone)

• Rash : Often acneiform or maculopapular. May require topical or oral corticosteroids.

• Fatigue : A frequent side effect; can impact daily activities. Encourage rest and hydration.

• Nausea and Vomiting : Usually mild to moderate. Anti-nausea medications may be used.

• Decreased appetite : Can lead to weight loss over time; nutritional support may be needed.

• Stomatitis (mouth sores) : May cause pain or difficulty eating. Use of mouthwashes or topical treatments may help.

• Grade 3/4 Diarrhea : Persistent or severe diarrhea may cause dehydration or kidney issues; hospitalization may be needed.

• Severe Rash or Skin Reactions : Can become extensive or blistering (e.g., Stevens-Johnson Syndrome – rare); may require corticosteroids and discontinuation.

• Severe Hyperglycemia : May need insulin or other glucose-lowering therapies temporarily.

• QT Prolongation (Heart Rhythm Disturbance) : Rare, but ECG monitoring may be needed in patients with cardiac history.

Capivasertib has demonstrated efficacy in improving progression-free survival in patients with AKT pathway alterations. In clinical trials, the combination of capivasertib and fulvestrant significantly reduced the risk of disease progression compared to fulvestrant alone.

• Cancer cells : Delays progression Proven to double progression-free survival

• Overcomes resistance : Makes tumors responsive again to hormone therapy

• Oral, convenient dosing : Easy to take at home with fewer interruptions

• Better tolerability : More manageable side effects than chemotherapy

LuciDela 150mg is a prescription medication containing Idelalisib, a potent oral drug used primarily in the treatment of certain blood cancers. This targeted therapy belongs to a class of drugs known as PI3K delta inhibitors and is particularly effective in treating chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL), and small lymphocytic lymphoma (SLL). Manufactured under strict pharmaceutical standards, LuciDela helps slow or stop the growth of malignant cells by interfering with key survival pathways in cancer cells.

Idelalisib, an anti-cancer drug found in LuciDela 150mg, targets particular signaling pathways in malignant white blood cells. It is used when the disease has relapsed or in patients who cannot tolerate other standard treatments. It’s often prescribed in combination with other drugs such as rituximab to enhance therapeutic outcomes in patients with blood malignancies.

The following conditions are approved for treatment with LuciDela 150mg:

• Relapsed Chronic Lymphocytic Leukemia (CLL) – typically in combination with rituximab.

• Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL) – for patients who have received at least two prior systemic therapies.

• Small Lymphocytic Lymphoma (SLL) – when other treatments fail.

• It is used under the supervision of a hematologist or oncologist experienced in cancer chemotherapy.

• The typical adult dosage is one 150 mg tablet taken orally twice a day, separated by around 12 hours.

• With or without food, LuciDela should be eaten whole with water.

• It is not recommended to chew or crush tablets.

• Do not take another dose if you experience nausea after taking one; instead, wait until the next scheduled dose.

LuciDela (Idelalisib) may cause both common and serious side effects. Regular monitoring is important during treatment.

• Diarrhea

• Fatigue

• Nausea

• Cough

• Abdominal pain

• Rash

• Fever

• Decreased appetite

• Severe diarrhea or colitis – May require dose reduction or discontinuation

• Liver toxicity – Elevated liver enzymes (ALT, AST); routine liver tests are essential

• Pneumonitis – Inflammation of the lungs causing cough, shortness of breath

• Serious infections – Pneumonia, CMV reactivation, sepsis; requires prompt treatment

• Severe skin reactions – Including Stevens-Johnson Syndrome (rare but serious)

• Neutropenia – Low white blood cells, increasing infection risk

Routine lab tests are advised to monitor liver enzymes, white blood cells, and infection markers throughout treatment.

LuciDela 150mg offers significant benefits for patients with limited treatment options:

• Targeted therapy with minimal effects on non-cancerous cells.

• Convenient oral dosing, avoiding hospital-based IV infusions.

• Improved progression-free survival in relapsed CLL and FL.

• Used as part of combination therapy for enhanced efficacy.

• Provides options for patients intolerant to chemotherapy.

A targeted cancer medicine called LuciPalbo 100mg is used to treat particular kinds of breast cancer. Palbociclib, a selective cyclin-dependent kinase (CDK) 4 and 6 inhibitor, is its active medicinal ingredient. This oral therapy has transformed the landscape of treatment for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced or metastatic breast cancer. LuciPalbo is typically used in combination with endocrine therapies, such as letrozole or fulvestrant, to enhance treatment outcomes.

Palbociclib, an antineoplastic agent categorized under CDK 4/6 inhibitors, is used in the formulation of the prescription drug LuciPalbo 100mg. By inhibiting proteins involved in cell division, it is used as part of combination therapy to halt the progression of breast cancer.  Most frequently, postmenopausal women or men with advanced HR+/HER2− breast cancer are prescribed it.

Palbociclib works by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6). These kinases are enzymes that regulate the cell cycle by facilitating progression from the G1 phase to the S phase, where DNA replication occurs. In HR+/HER2− breast cancer, the CDK4/6 pathway is often overactive, leading to uncontrolled cell proliferation.

By inhibiting CDK4/6, Palbociclib halts tumor cell growth and allows cancer cells to remain in a resting phase (G1), ultimately promoting cell death or senescence. When used alongside hormone therapies, which deprive the tumor of estrogen (a growth signal), LuciPalbo enhances the suppression of cancer progression.

LuciPalbo 100mg is indicated for use in:

• HR+/HER2− advanced or metastatic breast cancer

• In combination with an aromatase inhibitor (e.g., letrozole) as initial endocrine-based therapy in postmenopausal women or men.

• during the course of fulvestrant in patients whose condition has progressed after endocrine therapy.

• It is not recommended as monotherapy and should always be administered under oncological supervision.

Standard Dosage:

• The typical recommended dose is 125 mg once daily for 21 consecutive days, followed by 7 days off treatment (28-day cycle).

• Since LuciPalbo is 100mg, a combination of 1 x 100mg + 1 x 25mg tablet is usually prescribed to reach the 125mg dose.

Administration:

• Take orally with food at approximately the same time each day.

• Swallow the tablet whole—do not crush, chew, or split.

• If a dose is missed or vomiting occurs, do not take an additional dose; wait until the next scheduled dose

Like all cancer medications, LuciPalbo has a range of potential side effects, some of which may be serious. Common and serious side effects include:

• Neutropenia (low neutrophil count)

• Fatigue

• Nausea

• Diarrhea

• Hair thinning or loss (alopecia)

• Mouth sores

• Decreased appetite

• Infections (due to low white blood cells)

• Pulmonary embolism

• Liver function abnormalities

• Severe neutropenia requiring hospitalization

• Regular blood tests are necessary to monitor blood counts, especially during the first few cycles.

A targeted cancer medicine called LuciPalbo 125mg is used to treat particular kinds of breast cancer. Palbociclib, a selective cyclin-dependent kinase (CDK) 4 and 6 inhibitor, is its active medicinal ingredient. This oral therapy has transformed the landscape of treatment for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced or metastatic breast cancer. LuciPalbo is typically used in combination with endocrine therapies, such as letrozole or fulvestrant, to enhance treatment outcomes.

Palbociclib, an antineoplastic agent categorized under CDK 4/6 inhibitors, is used in the formulation of the prescription drug LuciPalbo 125mg. By inhibiting proteins involved in cell division, it is used as part of combination therapy to halt the progression of breast cancer.  Most frequently, postmenopausal women or men with advanced HR+/HER2− breast cancer are prescribed it.

Palbociclib works by selectively inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6). These kinases are enzymes that regulate the cell cycle by facilitating progression from the G1 phase to the S phase, where DNA replication occurs. In HR+/HER2− breast cancer, the CDK4/6 pathway is often overactive, leading to uncontrolled cell proliferation.

By inhibiting CDK4/6, Palbociclib halts tumor cell growth and allows cancer cells to remain in a resting phase (G1), ultimately promoting cell death or senescence. When used alongside hormone therapies, which deprive the tumor of estrogen (a growth signal), LuciPalbo enhances the suppression of cancer progression.

LuciPalbo 125mg is indicated for use in:

• HR+/HER2− advanced or metastatic breast cancer

• In combination with an aromatase inhibitor (e.g., letrozole) as initial endocrine-based therapy in postmenopausal women or men.

• during the course of fulvestrant in patients whose condition has progressed after endocrine therapy.

• It is not recommended as monotherapy and should always be administered under oncological supervision.

Standard Dosage:

• The typical recommended dose is 125 mg once daily for 21 consecutive days, followed by 7 days off treatment (28-day cycle).

• Since LuciPalbo is 125mg, a combination of 1 x 100mg + 1 x 25mg tablet is usually prescribed to reach the 125mg dose.

Administration:

• Take orally with food at approximately the same time each day.

• Swallow the tablet whole—do not crush, chew, or split.

• If a dose is missed or vomiting occurs, do not take an additional dose; wait until the next scheduled dose

LuciPalbo (Palbociclib) is also available in other strengths:

• 75mg

• 125mg

These varying strengths allow personalized dose adjustments based on tolerability and side effects, especially for patients who experience hematologic toxicities or require dose reductions.

Like all cancer medications, LuciPalbo has a range of potential side effects, some of which may be serious. Common and serious side effects include:

• Neutropenia (low neutrophil count)

• Fatigue

• Nausea

• Diarrhea

• Hair thinning or loss (alopecia)

• Mouth sores

• Decreased appetite

• Infections (due to low white blood cells)

• Pulmonary embolism

• Liver function abnormalities

• Severe neutropenia requiring hospitalization

• Regular blood tests are necessary to monitor blood counts, especially during the first few cycles.

LuciRibo 200mg contains Ribociclib, a targeted cancer therapy drug primarily used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It belongs to a class of medications known as CDK4/6 inhibitors, which help in halting the growth of cancer cells by interfering with cell cycle progression. Manufactured under strict pharmaceutical guidelines, LuciRibo offers patients a potent and well-tolerated option for cancer control in combination with hormone therapies.

LuciRibo (Ribociclib) is an oral prescription medication used alongside hormone therapy (like letrozole or fulvestrant) to treat advanced or metastatic breast cancer in postmenopausal women or men. It is especially used for cancers that are HR+ and HER2-, which means they rely on hormones for growth and are not fueled by HER2 proteins.

Ribociclib targets cancer at the molecular level, aiming to suppress tumor proliferation more precisely than traditional chemotherapies, with fewer systemic effects.

Ribociclib functions by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), enzymes essential for cell cycle progression from the G1 to S phase. In HR+ breast cancer cells, CDK4/6 is frequently overactive, leading to uncontrolled cell division.

By blocking CDK4/6:

• The cell cycle is arrested.

• Cancer cell growth is suppressed.

• Apoptosis (programmed cell death) may be triggered.

This action is synergistic when used with hormone therapies like aromatase inhibitors or selective estrogen receptor degraders (SERDs), making the combination more effective than either agent alone.

Indications for LuciRibo include:

• First-line treatment for HR+/HER2- advanced or metastatic breast cancer in postmenopausal women, in combination with letrozole.

• For HR+/HER2- advanced or metastatic breast cancer regardless of menopausal status, in combination with fulvestrant.

• In men, LuciRibo is used similarly along with hormone therapies and LHRH agonists.

Note: LuciRibo is not used as a standalone therapy but always in combination with hormone-modulating agents.

The standard recommended dose of LuciRibo is:

• 600 mg used once daily for 21 days in a row (three 200 mg tablets), with 7 days off in between (a 28-day treatment cycle).

• It is often taken at the same time every day, with or without food. It is best to swallow tablets whole with water rather than breaking, chewing, or splitting them.

• Close monitoring is needed with periodic complete blood counts, liver function tests, and ECGs due to potential side effects.

Like most cancer therapies, LuciRibo may cause both common and serious side effects.

• Nausea

• Fatigue

• Diarrhea

• Hair thinning

• Vomiting

• Rash

• Headache

• Constipation

• Neutropenia (low white blood cells)

• Hepatotoxicity (liver dysfunction)

• QT interval prolongation (heart rhythm disorder)

• Infections

• Anemia or thrombocytopenia

• Elevated liver enzymes (AST, ALT)

• Patients should immediately report symptoms like fever, chills, chest pain, irregular heartbeat, or yellowing of eyes/skin.

Product introduction

Kryxana 200mg Tablet is an anti-cancer medicine used in the treatment of metastatic breast cancer. It helps to slow down the growth of cancer cells and eventually kills them. This way it treats the symptoms of breast cancer such as breast lumps, bloody discharge from nipples, or changes in the shape of the breast.

 Kryxana 200mg Tablet may be taken with or without food and usually taken in combination with another medicine. The duration of treatment varies on the basis of your need and response to treatment. Take it in the exact dose and duration prescribed by your doctor. You may be asked for regular blood tests while taking this medication.

 Common side effects of this medicine include decreased white blood cell count, nausea, fatigue, diarrhea, hair loss, vomiting, constipation, headache, and back pain. Neutropenia is a well-recognized adverse effect, in which the number of your white blood cells get reduced and your immune system gets weakened. As a result, you may be at greater risk of getting an infection. However, this side effect disappears rapidly once you stop taking the medicine.

 Uses of Kryxana Tablet

Metastatic breast cancer

Benefits of Kryxana Tablet

In Metastatic breast cancer

Kryxana 200mg Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kryxana 200mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Side effects of Kryxana Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Kryxana

• Decreased white blood cell count
• Nausea
• Fatigue
• Diarrhea
• Hair loss
• Vomiting
• Constipation
• Headache
• Back pain

Safety advice

Alcohol

It is not known whether it is safe to consume alcohol with Kryxana 200mg Tablet.

Pregnancy

Kryxana 200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you.

Breast feeding

Kryxana 200mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

Kryxana 200mg Tablet may cause side effects which could affect your ability to drive.

Some people may experience fatigue, dizziness, or vertigo during treatment with Kryxana 200mg Tablet. If these happen you should be cautious when driving or using machines.

Kidney

Kryxana 200mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Kryxana 200mg Tablet may not be needed in these patients. Please consult your doctor.

Liver

Kryxana 200mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Kryxana 200mg Tablet may be needed. Please consult your doctor.

Enhertu (fam-trastuzumab deruxtecan-nxki) 100mg Injection

Product Description

Enhertu 100mg Injection is used in the treatment of early as well as metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.

Enhertu 100mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

PRODUCT INTRODUCTION

Herclon Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Herclon Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

USES OF HERCLON INJECTION

• Breast cancer

• Stomach cancer

BENEFITS OF HERCLON INJECTION

In Breast cancer

Herclon Injection is used to treat breast cancer when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. This medicine is given as an injection by a doctor or nurse. Follow your doctor’s instructions carefully to get the most benefit.

In Stomach cancer

Stomach cancer also known as gastric cancer, may occur in the inner lining (called mucosa) of the stomach or in the walls of the stomach. These are of various kinds depending on the origin, affected area and severity of the cancer. Herclon Injection helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor’s instructions carefully to get the most benefit.

SIDE EFFECTS OF HERCLON INJECTION

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Herclon

• Anemia (low number of red blood cells)

• Chills

• Common cold

• Cough

• Decreased blood cells (red cells, white cells, and platelets)

• Diarrhea

• Fatigue

• Fever

• Headache

• Heart failure

• Infection

• Insomnia (difficulty in sleeping)

• Mucosal inflammation

• Nausea

• Rash

• Stomatitis (Inflammation of the mouth)

• Taste change

• Upper respiratory tract infection

• Weight loss

HOW TO USE HERCLON INJECTION

Your doctor or nurse will give you this medicine. Kindly do not self administer.

WHAT IF YOU FORGET TO TAKE HERCLON INJECTION?

If you miss a dose of Herclon Injection, please consult your doctor.